Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Farmers Insurance
Accenture
Federal Trade Commission
McKinsey
Boehringer Ingelheim
Deloitte
Merck
Cipla

Generated: April 27, 2018

DrugPatentWatch Database Preview

MELLARIL-S Drug Profile

« Back to Dashboard

When do Mellaril-s patents expire, and when can generic versions of Mellaril-s launch?

Mellaril-s is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in MELLARIL-S is thioridazine. There are eighteen drug master file entries for this compound. Additional details are available on the thioridazine profile page.
Drug patent expirations by year for MELLARIL-S
Medical Subject Heading (MeSH) Categories for MELLARIL-S
Synonyms for MELLARIL-S
(.+/-.)-Thioridazine
(+-)-Thioridazine
(Thioridazine)10-[2-(1-Methyl-piperidin-2-yl)-ethyl]-2-methylsulfanyl-10H-phenothiazine
10-(2-(1-Methyl-2-piperidyl)ethyl)-2-(methylthio)phenothiazine
10-(2-(1-Methylpiperidin-2-yl)ethyl)-2-(methylthio)-10H-phenothiazine
10-[2-(1-Methyl-2-piperidinyl)ethyl]-2-(methylsulfanyl)-10H-phenothiazine
10-[2-(1-Methyl-2-piperidinyl)ethyl]-2-(methylsulfanyl)-10H-phenothiazine #
10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine
10-[2-(1-methyl-piperidin-2-yl)-ethyl]-2-methylsulfanyl-10h-phenothiazine
10-[2-(1-Methyl-piperidin-2-yl)-ethyl]-2-methylsulfanyl-10H-phenothiazine (thioridazine)
10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylsulfanyl)-10H-phenothiazine
10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylthio)-10H-phenothiazine
10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine
10H-Phenothiazine, 10-(2-(1-methyl-2-piperidinyl)ethyl)-2-(methylthio)-
10H-Phenothiazine, 10-[2-(1-methyl-2-piperidinyl)ethyl]-2-(methylthio)-
10H-Phenothiazine, 10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylthio-
1452-EP2272537A2
1452-EP2275420A1
1452-EP2298776A1
2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine
242T875
3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine
3B1-005678
50-52-2
57129-06-3
6960AB
AB00053553
AB00053553_17
AB00053553_18
AB00053553-16
AC1L1KDN
AI3-51923
AK117758
AKOS016000682
Aldazine
AN-41562
API0003283
AX8153985
BDBM50002338
Biomol-NT_000017
BPBio1_000325
BPBio1_001175
BSPBio_000295
BSPBio_002030
C21H26N2S2
CAS-50-52-2
CCG-205326
CHEBI:9566
CHEMBL479
cMAP_000015
D00373
D0U1OE
DB00679
DivK1c_000066
dl-Thioridazine
DSSTox_CID_3656
DSSTox_GSID_23656
DSSTox_RID_77130
DTXSID6023656
EINECS 200-044-2
GTPL100
HMS2090J04
HSDB 3189
IDI1_000066
KB-217584
KBio1_000066
KBio2_001546
KBio2_002308
KBio2_004114
KBio2_004876
KBio2_006682
KBio2_007444
KBio3_001530
KBio3_002788
KBioGR_000791
KBioGR_002308
KBioSS_001546
KBioSS_002310
KLBQZWRITKRQQV-UHFFFAOYSA-N
L001321
Lopac0_001252
LS-105605
Mallorol
Malloryl
MCULE-7796139302
Meleril
Mellaril
Mellaril (*Hydrochloride*)
Mellaril (Salt/Mix)
Mellaril (TN)
Mellaril-S (TN)
Mellarit
Mellerets
Mellerette
Melleretten
Melleril
Melleril (liquid)
Melleryl
Metlaril
NCGC00016059-03
NCGC00016059-04
NCGC00016059-05
NCGC00016059-07
NCGC00016059-08
NCGC00016059-09
NCGC00016059-10
NCGC00016059-11
NCGC00016059-13
NCGC00016059-14
NCGC00089809-02
NCGC00089809-03
NINDS_000066
Novoridazine
Novoridazine (TN)
NS-835
NSC186060
Orsanil
Phenothiazine, 10-((1-methyl-2-piperidyl)ethyl)-2-(methylthio)-
Phenothiazine, 10-[2-(1-methyl-2-piperidyl)ethyl]-2-(methylthio)-
PL007338
PL057675
Prestwick0_000078
Prestwick1_000078
Prestwick2_000078
Prestwick3_000078
Ridazine
SBI-0051219.P004
SC-19270
SCHEMBL12434241
SCHEMBL9566
Sonapax
SPBio_001483
SPBio_002216
Spectrum_001066
Spectrum2_001332
Spectrum3_000585
Spectrum4_000356
Spectrum5_001062
Stalleril
Thioridazin
thioridazine
Thioridazine (USP/INN)
Thioridazine [USAN:INN:BAN]
Thioridazine [USAN:USP:INN:BAN]
Thioridazine Hcl
Thioridazine Hcl Intensol
Thioridazine prolongatum
Thioridazine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
Thioridazine, prolongatum
Thioridazinum
Thioridazinum [INN-Latin]
Thioril (TN)
Thioxidazine
Thiozine
Thoridazine hydrochloride
Tioridazin
Tioridazina
Tioridazina [INN-Spanish]
Tox21_110294
Tox21_110294_1
TP-21

US Patents and Regulatory Information for MELLARIL-S

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis MELLARIL-S thioridazine SUSPENSION;ORAL 017923-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis MELLARIL-S thioridazine SUSPENSION;ORAL 017923-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Cantor Fitzgerald
AstraZeneca
Moodys
Cipla
Harvard Business School
Covington
Citi
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.